Compare ZTO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTO | MEDP |
|---|---|---|
| Founded | 2002 | 1992 |
| Country | China | United States |
| Employees | 23913 | N/A |
| Industry | Advertising | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 14.9B |
| IPO Year | N/A | 2016 |
| Metric | ZTO | MEDP |
|---|---|---|
| Price | $25.02 | $516.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 13 |
| Target Price | $23.32 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 1.6M | 260.5K |
| Earning Date | 05-19-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $13.49 | $13.19 |
| Revenue Next Year | $8.90 | $7.75 |
| P/E Ratio | ★ $21.83 | $32.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.68 | $250.05 |
| 52 Week High | $26.20 | $628.92 |
| Indicator | ZTO | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 62.84 |
| Support Level | $23.25 | $489.09 |
| Resistance Level | $25.52 | $622.32 |
| Average True Range (ATR) | 0.52 | 16.86 |
| MACD | -0.00 | 4.85 |
| Stochastic Oscillator | 87.94 | 87.06 |
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.